KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Esperion Therapeutics (ESPR) Inventory Average (2020 - 2025)

Historic Inventory Average for Esperion Therapeutics (ESPR) over the last 6 years, with Q3 2025 value amounting to $111.5 million.

  • Esperion Therapeutics' Inventory Average rose 3550.69% to $111.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $111.5 million, marking a year-over-year increase of 3550.69%. This contributed to the annual value of $80.1 million for FY2024, which is 5880.54% up from last year.
  • Latest data reveals that Esperion Therapeutics reported Inventory Average of $111.5 million as of Q3 2025, which was up 3550.69% from $106.9 million recorded in Q2 2025.
  • Over the past 5 years, Esperion Therapeutics' Inventory Average peaked at $111.5 million during Q3 2025, and registered a low of $18.1 million during Q1 2021.
  • Moreover, its 5-year median value for Inventory Average was $42.5 million (2023), whereas its average is $55.4 million.
  • As far as peak fluctuations go, Esperion Therapeutics' Inventory Average soared by 33358.11% in 2021, and later crashed by 529.5% in 2022.
  • Esperion Therapeutics' Inventory Average (Quarter) stood at $34.2 million in 2021, then decreased by 5.3% to $32.4 million in 2022, then soared by 80.8% to $58.5 million in 2023, then skyrocketed by 49.15% to $87.3 million in 2024, then rose by 27.73% to $111.5 million in 2025.
  • Its Inventory Average stands at $111.5 million for Q3 2025, versus $106.9 million for Q2 2025 and $96.9 million for Q1 2025.